Serum soluble interleukin-2 receptor levels in familial Mediterranean fever

Annals of the Rheumatic Diseases

Volumn 55, Issue 11, 1996, Pages 852-855

  Erken, Eren ^a   Güneşaçar, Ramazan ^a   Özbek, Süleyman ^a   Konca, Kamuran ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 RECEPTOR;

ADULT; ARTICLE; BLOOD LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

EID: 0029834376     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.55.11.852     Document Type: Article

References (16)

1. Lightfoot RW. Intermittent and periodic arthritic syndromes. In: McCarty DJ, ed. Arthritis and allied conditions, 12th ed. Philadelphia: Lea and Febiger, 1993:1121-37.
2. Schattner A, Lachmi M, Livneh A, Pras M, Hahn T. Tumor necrosis factor in familial Mediterranean fever. Am J Med 1991;90:434-8.
3. Rozenbaum M, Katz R, Rozner I, Pollack S. Decreased interleukin-1 activity released from circulating monocytes of patients with familial Mediterranean fever during in vitro stimulation by lipopolysaccharide. J Rheumatol 1992; 19:416-88.
4. Pepys MB. Aspects of acute phase response. The C-reactive protein system. In: Lachman PJ, Peters DK, eds. Clinical aspects of immunology, 4th ed. Oxford: Blackwell Scientific Publications, 1982:50-69.
5. Knecht A, de Beer FC, Pras M. Serum amyloid A protein in familial Mediterranean fever. Ann Intern Med 1985; 102:71-2.
6. Erken E, Demirtaş M. Serum amyloid A in familial Mediterranean fever [abstr]. Hungarian Rheumatol 1991; 32(suppl):P1-28.
7. Matzner Y, Brzezinski A. C5a inhibitor deficiency in peritoneal fluid from patients with familial Mediterranean fever. N Engl J Med 1984;311:287-90.
8. Matzner Y, Patridge RE, Levy M, Babior BM. Diminished activity of a chemotactic inhibitor in synovial fluids from patients with familial Mediterranean fever. Blood 1984; 63:629-99.
9. Ilfeld D, Weil S, Kuperman O. Immunoregulatory abnormalities in familial Mediterranean fever. Clin Immunol Immunopathol 1981;18:261-7.
10. Oppenheim JJ, Ruscetti FW, Faltynek C. Cytokines. In: Stites P, Terr AI, Parslow TG, eds. Basic and clinical immunology, 8th ed. Northwalk: Appleton and Lange, 1994:105-23.
11. Matsumoto T, Iwasaki K. Clinical and laboratory parameterseters which effect soluble interleukin-2 receptor levels in the serum and synovial fluids of patients with rheumatoid arthritis. Ann Rheum Dis 1993;52:876-80.
12. Keystone EC, Snow KM, Bombardieri C, Chang C, Nelson DL, Rubin LA. Elevated soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis. Arthritis Rheum 1988;31:844-9.
13. Campen DH, Horwitz DA, Quismorio FP, Ehresmann GR, Martin WJ. Serum levels of interleukin-2 receptor and activity of rheumatic diseases characterized by immune system activation. Arthritis Rheum 1988;31:1358-63.
14. Wolf RE, Brelsford WG. Soluble interleukin-2 receptors in systemic lupus erythematosus. Arthritis Rheum 1988; 31:729-35.
15. Lansbury J, Haut DD. Quantification of the manifestations of rheumatoid arthritis. 4. Area of joint surfaces as an index to total joint inflammation and deformity. Am J Med Sci 1956;232:150-5.
16. Melamed A, Cabili S, Zakuth V, Spirer Z. The immune regulation in familial Mediterranean fever (FMF). J Clin Lab Immunol 1988;26:125-8.